recombinant long-acting erythropoietin (Hangzhou Anruipu Biological Technology)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant long-acting erythropoietin (Hangzhou Anruipu Biological Technology)
Drug Alias Namenovel erythropoietic stimulating protein (Hangzhou Anruipu Biological Technology)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemiaRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHangzhou Anruipu Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHangzhou Anruipu Biological Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsAnemiaRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A